The Oncology Institute (TOIIW) Stock Analysis
NASDAQHealthcareMedical - Care Facilities
What The Oncology Institute does
The Oncology Institute, Inc. operates as a U.S.-based firm, specializing in providing extensive medical oncology services. Its comprehensive offerings encompass direct physician care, integrated on-site infusion and pharmacy services, clinical research initiatives, outpatient stem cell transplant and transfusion programs, and dedicated patient support. The company also oversees and manages specialized programs, including palliative care and stem cell transplants, specifically designed to meet the needs of cancer patients. Established in 2007, its headquarters are located in Cerritos, California.
Key metrics
ETFs linked to TOIIW
Broad-market and Healthcare sector ETFs an investor holding The Oncology Institute is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how TOIIW fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze TOIIW in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for The Oncology Institute?
- The Oncology Institute trades under the ticker TOIIW on NASDAQ.
- Which exchange is TOIIW listed on?
- TOIIW is listed on NASDAQ.
- What sector does The Oncology Institute operate in?
- The Oncology Institute is classified in the Healthcare sector (Medical - Care Facilities industry).
- How can PortView help analyze TOIIW in a portfolio?
- PortView shows TOIIW's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.